ArticleThe New England journal of medicine2022
Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria.
Richard L Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
79 papers cite itlatest 60 shown
this papertrialcites it